| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/02/2005 | CN1587261A Imidazole-2-ketone compound and its preparing method and use |
| 03/02/2005 | CN1191293C 2-phenylmidezole-phospyhate as accelerator for acid anhydride curing agent in epoxy composition in a separated container |
| 03/02/2005 | CN1191051C Application of cation mono-benzol nitrophenylamine in keratin fiber dyeing dye composition and dyeing method |
| 03/02/2005 | CN1191049C Cationic monophenyl-nitro-diamino compounds and use in dyeing cutin fiber, dyeing composition containing said matter |
| 03/01/2005 | US6861556 For example, 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3 methyl 3-H-imidazol-1-ium chloride; prepared by reacting an aminophenol with a haloacetyl chloride, reducing product with borane-tetrahydrofuran complex, reacting compound with amine |
| 03/01/2005 | US6861534 Process for producing 1,3-dialkyl-2-imidazolidinone compound |
| 03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
| 03/01/2005 | US6861456 Photosensitive compound, photosensitive resin, and photosensitive composition |
| 03/01/2005 | US6861432 Piperazine derivatives that destabilize androgen receptors |
| 03/01/2005 | US6861232 Creatinine biosensor |
| 03/01/2005 | CA2288334C Method of manufacturing sertindole |
| 02/24/2005 | WO2005016941A1 N-heterocyclic carbenes that can be immobilized |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2004094395A3 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 02/24/2005 | WO2004087066A3 Hif-1 inhibitors |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043403 Reacting carboxamide compound with sulphuric diester to form imidic ester alkyl sulfate; then reacting with ammonia to form amidinium alkyl sulfate |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043384 and methylene diol of about 580-1385 ppm, activity against the organism Burkholderia cepacia in combination with other biocides such as parabens and iodopropynyl butyl carbamate (IPBC) |
| 02/24/2005 | US20050043368 Osteoporosis therapy; bone disorders |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050039268 Use of dicatonic compounds for dyeing human keratinous fibres and compositions containing the same |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507541A2 Inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0929519B1 Beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585639A Antimalarial agents |
| 02/23/2005 | CN1583726A Chiral ion liquid of alkylimidazole tetrafluoroborate and its preparation |
| 02/23/2005 | CN1190426C Method for resolving D-biotin intermediate racemic semi-ester |
| 02/22/2005 | US6858720 Forming nucleotide bond; obtain nucleotide sequences reaction mixture, contact with the free hydroxyl of a growing polynucleotide, recover nucleic acid |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858637 Treating rheumatoid arthritis, psoriasis, cardiovascular disease, reperfusion injury, and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 02/22/2005 | US6858636 Angiotensin II antagonists for treating cardiovascular disorders, hypertension, congestive heart failure and glaucoma. |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858594 Compounds and methods for treating urinary incontinence |
| 02/22/2005 | US6858396 Amino acids where primary amine group is replaced by azide; use in peptides screening for bioactivity, crossing blood-brain barrier, increasing selectivity; treating brain disorders |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005015215A1 Novel chemiluminescent compounds and their use |
| 02/17/2005 | WO2005014555A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 02/17/2005 | US20050038260 Intermediate for biotin and process for producing the same |
| 02/17/2005 | US20050038236 Imidazolidinone derivatives |
| 02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia |
| 02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050037995 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 02/17/2005 | CA2532910A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 02/16/2005 | EP1506177A2 Process for the preparation of the enantiomeric forms of 2-substituted 2-(2,5-dioxoimidazolidin-1-yl)-acetic acid derivatives |
| 02/16/2005 | EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 02/16/2005 | EP1506168A2 Gelling agents |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506162A2 Synthesis of benzonitriles and benzimidates |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | EP1068200B1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 02/16/2005 | CN1582279A Peroxisome proliferator activated receptor agonists |
| 02/16/2005 | CN1580056A Heterocyclic derivatives their preparing methods and uses |
| 02/16/2005 | CN1580048A Radiochemical therapy sensitivity-enhancing agent-glycididazole meglumine salt, and its preparing method and use |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855828 Administering to a mammal a fluorine-18 containing 2-nitro-n-(carboxamidomethyl)imidazole derivatives and imaging |
| 02/15/2005 | US6855702 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855174 Couplers for use in oxidative hair dyeing |
| 02/15/2005 | CA2265539C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
| 02/10/2005 | WO2005012245A1 Novel heteroaryl derivative |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005011683A1 Transdermal absorption preparation |
| 02/10/2005 | WO2005011682A1 Sustained release tablet for oral use |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | WO2004092447A3 Imidazoline corrosion inhibitors |
| 02/10/2005 | US20050033060 Radiolabelled phenylethyl imidazole caboxylic acid ester derivatives |
| 02/10/2005 | US20050033039 Compounds with perfluoroalkanoacetophenone groups that form complexes with rare earth elements that can be used in immunoassays or nucleic acid assays for labeling a protein, peptide, amino acid, nucleic acid, or nucleotide |
| 02/10/2005 | US20050032865 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050031903 Multilayer; charge generating compound, charge transfer compound; blue phosphorescence |
| 02/10/2005 | US20050029086 Mixture containing impurities, base; controlling alkalinity; purification |
| 02/10/2005 | US20050028300 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds |
| 02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
| 02/09/2005 | EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1453816A4 Phenoxy amine compounds and compositions for delivering active agents |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1117399B1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 02/09/2005 | EP1100789B1 Substituted benzoylcyclohexandiones |
| 02/09/2005 | CN1578771A Developer components and their use for dyeing keratinic fibers |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |